Humankind Investments’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.33M | Buy |
12,360
+1,571
| +15% | +$169K | 0.32% | 42 |
|
|
2025
Q1 | $1.09M | Sell |
10,789
-1,887
| -15% | -$190K | 0.28% | 52 |
|
|
2024
Q4 | $1.13M | Sell |
12,676
-654
| -5% | -$58.4K | 0.29% | 49 |
|
|
2024
Q3 | $1.12M | Buy |
13,330
+67
| +0.5% | +$5.62K | 0.4% | 46 |
|
|
2024
Q2 | $1.02M | Buy |
13,263
+2,598
| +24% | +$200K | 0.27% | 51 |
|
|
2024
Q1 | $730K | Sell |
10,665
-1,354
| -11% | -$92.7K | 0.19% | 61 |
|
|
2023
Q4 | $695K | Sell |
12,019
-1,081
| -8% | -$62.5K | 0.21% | 60 |
|
|
2023
Q3 | $692K | Buy |
13,100
+709
| +6% | +$37.4K | 0.29% | 48 |
|
|
2023
Q2 | $670K | Buy |
12,391
+6,277
| +103% | +$340K | 0.26% | 50 |
|
|
2023
Q1 | $306K | Sell |
6,114
-529
| -8% | -$26.5K | 0.13% | 88 |
|
|
2022
Q4 | $307K | Sell |
6,643
-113
| -2% | -$5.23K | 0.13% | 88 |
|
|
2022
Q3 | $262K | Buy |
6,756
+648
| +11% | +$25.1K | 0.13% | 90 |
|
|
2022
Q2 | $228K | Sell |
6,108
-3,695
| -38% | -$138K | 0.11% | 97 |
|
|
2022
Q1 | $434K | Sell |
9,803
-4
| -0% | -$177 | 0.18% | 72 |
|
|
2021
Q4 | $417K | Buy |
9,807
+1,676
| +21% | +$71.3K | 0.53% | 62 |
|
|
2021
Q3 | $353K | Buy |
8,131
+632
| +8% | +$27.4K | 0.54% | 62 |
|
|
2021
Q2 | $321K | Buy |
+7,499
| New | +$321K | 0.57% | 56 |
|